Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.4 (
kinesin
)
5,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Early onset dystonia is a movement disorder caused by loss of a glutamic acid residue (Glu(302/303)) in the carboxyl-terminal portion of the AAA+ protein,
torsinA
. We identified the light chain subunit (KLC1) of
kinesin
-I as an interacting partner for
torsinA
, with binding occurring between the tetratricopeptide repeat domain of KLC1 and the carboxyl-terminal region of
torsinA
. Coimmunoprecipitation analysis demonstrated that wild-type
torsinA
and
kinesin
-I form a complex in vivo. In cultured cortical neurons, both proteins co-localized along processes with enrichment at growth cones. Wild-type
torsinA
expressed in CAD cells co-localized with endogenous KLC1 at the distal end of processes, whereas mutant
torsinA
remained confined to the cell body. Subcellular fractionation of adult rat brain revealed
torsinA
and KLC associated with cofractionating membranes, and both proteins were co-immunoprecipitated after cross-linking cytoplasmically oriented proteins on isolated rat brain membranes. These studies suggest that wild-type
torsinA
undergoes anterograde transport along microtubules mediated by
kinesin
and may act as a molecular chaperone regulating
kinesin
activity and/or cargo binding.
...
PMID:The early onset dystonia protein torsinA interacts with kinesin light chain 1. 1497 Jan 96